stoxline Quote Chart Rank Option Currency Glossary
Scorpius Holdings, Inc. (SCPX)
0.0763  -0.021 (-21.34%)    06-14 13:36
Open: 0.0956
High: 0.0967
Volume: 16,627,013
Pre. Close: 0.097
Low: 0.075
Market Cap: 8(M)
Technical analysis
2024-06-21 4:55:11 PM
Short term     
Mid term     
Targets 6-month :  0.16 1-year :  0.22
Resists First :  0.14 Second :  0.18
Pivot price 0.11
Supports First :  0.07 Second :  0.05
MAs MA(5) :  0.09 MA(20) :  0.11
MA(100) :  0.2 MA(250) :  0.39
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  10.5 D(3) :  16.3
RSI RSI(14): 33.9
52-week High :  0.74 Low :  0.07
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SCPX ] has closed below the lower bollinger band by 15.9%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SCPX ] is to continue within current trading range. It is unclear right now based on current values. 47.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.1 - 0.1 0.1 - 0.1
Low: 0.07 - 0.07 0.07 - 0.07
Close: 0.08 - 0.08 0.08 - 0.08
Company Description

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Headline News

Mon, 17 Jun 2024
Scorpius Holdings faces NYSE delisting over low stock price By -

Mon, 17 Jun 2024
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal - StockTitan

Mon, 17 Jun 2024
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal - Yahoo Finance

Fri, 14 Jun 2024
NYSE American to Commence Delisting Proceedings Against Scorpius Holdings, Inc. (SCPX) - WICZ

Mon, 03 Jun 2024
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered ... - Markets Insider

Wed, 29 May 2024
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024 - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android